SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 136 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2018. The put-call ratio across all filers is 1.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $433,000 | -43.6% | 254,541 | -42.3% | 0.04% | -93.4% |
| Q2 2018 | $768,000 | +7.3% | 441,461 | +78.7% | 0.68% | +600.0% |
| Q3 2017 | $716,000 | -34.8% | 247,030 | 0.0% | 0.10% | -40.9% |
| Q2 2017 | $1,099,000 | +285.6% | 247,030 | +304.3% | 0.16% | +221.6% |
| Q1 2017 | $285,000 | -15.2% | 61,108 | +10.6% | 0.05% | -49.0% |
| Q4 2016 | $336,000 | -10.6% | 55,250 | -19.1% | 0.10% | -45.1% |
| Q3 2016 | $376,000 | +45.2% | 68,254 | 0.0% | 0.18% | -5.2% |
| Q2 2016 | $259,000 | +115.8% | 68,254 | +57.5% | 0.19% | +16.4% |
| Q1 2016 | $120,000 | -54.0% | 43,341 | -5.9% | 0.16% | -77.0% |
| Q4 2015 | $261,000 | – | 46,043 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
| Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
| Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
| Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
| Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
| Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
| Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
| CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
| KNOTT DAVID M | 158,400 | $459,000 | 0.20% |